Nasdaq Mdvl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq mdvl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Mdvl Today - Breaking & Trending Today

MedAvail (NASDAQ:MDVL) Trading Up 29.4%

MedAvail Holdings, Inc. (NASDAQ:MDVL – Get Rating) shares were up 29.4% on Thursday . The stock traded as high as $0.39 and last traded at $0.33. Approximately 748,576 shares were traded during mid-day trading, an increase of 283% from the average daily volume of 195,333 shares. The stock had previously closed at $0.26. Wall Street […] ....

Pharmacy Technology , Millennium Management , Renaissance Technologies , Virtu Financial , Alyeska Investment Group , Retail Pharmacy Services , Medavail Holdings Inc , Medavail Company Profile , Medavail Pharmacy Inc , Medavail Holdings , Get Rating , Lake Street Capital , Avail Stock Down , Avail Holdings , Medavail Daily , Nasdaq Mdvl ,

MedAvail (NASDAQ:MDVL) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of MedAvail (NASDAQ:MDVL – Get Rating) from a hold rating to a buy rating in a research report released on Saturday morning, Zacks.com reports. Zacks Investment Research currently has $1.50 price objective on the stock. According to Zacks, “MedAvail Holding Inc. is a technology-enabled pharmacy organization. It engages in providing […] ....

United States , Medavail Medcenter , Morgan Stanley , Board Of Administration Florida Retirement System , Technology Inc , Zacks Investment Research , Renaissance Technologies , Medavail Holding Inc , Medavail Holdings Inc , Medavail Ltd Abg , Citadel Advisors , Get Rating , Investment Research , Avail Holding , Avail Holding Inc , Wtt Medavail Ltd Abg , Street Group , Florida Retirement System , Avail Holdings , Nasdaq Mdvl ,

MedAvail (NASDAQ:MDVL) Posts Earnings Results, Misses Expectations By $0.04 EPS

MedAvail (NASDAQ:MDVL – Get Rating) released its quarterly earnings data on Thursday. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.34) by ($0.04), MarketWatch Earnings reports. MedAvail had a negative net margin of 241.08% and a negative return on equity of 87.61%. During the same quarter last year, […] ....

Thomson Reuter , Medavail Medcenter , Medavail Holdings Inc , Zacks Investment Research , Citadel Advisors , Renaissance Technologies , Millennium Management , Get Rating , Marketwatch Earnings , Street Corp , Jane Street Group , Avail Holdings , Nasdaq Mdvl ,